Background: Research suggests that posttraumatic stress disorder (PTSD) is associated with metabolic syndrome (MetS) and that PTSD-associated MetS is related to decreased cortical thickness. However, the role of genetic factors in these associations is unclear. This study evaluated contributions of polygenic obesity risk and PTSD to MetS and of MetS and polygenic obesity risk to cortical thickness. Methods: 196 white, non-Hispanic veterans of the wars in Iraq and Afghanistan underwent clinical diagnostic interviews, physiological assessments, and genome-wide genotyping; 168 also completed magnetic resonance imaging scans. Polygenic risk scores (PRSs) for obesity were calculated from results of a prior genome-wide association study (Speliotes et al., 2010) and PTSD and MetS severity factor scores were obtained. Results: Obesity PRS (b = 0.15, p = 0.009) and PTSD (b = 0.17, p = 0.005) predicted MetS and interacted such that the association between PTSD and MetS was stronger in individuals with greater polygenic obesity risk (b = 0.13, p = 0.02). Whole-brain vertex-wise analyses suggested that obesity PRS interacted with MetS to predict decreased cortical thickness in left rostral middle frontal gyrus (b = À0.40, p < 0.001). Conclusions: Results suggest that PTSD, genetic variability, and MetS are related in a transactional fashion wherein obesity genetic risk increases stress-related metabolic pathology, and compounds the ill health effects of MetS on the brain. Genetic proclivity towards MetS should be considered in PTSD patients when prescribing psychotropic medications with adverse metabolic profiles. Results are consistent with a growing literature suggestive of PTSD-related accelerated aging.
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Posttraumatic stress disorder (PTSD) is associated with elevated risk for metabolic syndrome (MetS; Rosenbaum et al., 2015b), a condition defined by obesity, dyslipidemia, hypertension, and elevated blood sugars (National Cholesterol Education Program (NCEP), 2001). MetS is a major risk factor for the development of cardiac disease, type 2 diabetes, and other common medical conditions (Wilson et al., 2005) . Two recent meta-analyses found that the prevalence of MetS was approximately two times higher in PTSD samples compared to controls, with an estimated prevalence of approximately 40% (Bartoli et al., 2013; Rosenbaum et al., 2015b) . Moreover, a recent longitudinal study of young veterans returning from the wars in Iraq and/or Afghanistan found evidence of premature development of MetS among those with PTSD and suggested that PTSD severity was associated with increasing metabolic risk over time (Wolf et al., 2016a) .
